The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Identification of a novel FGF, FGF-21, preferentially expressed in the liver
Abstract
We isolated cDNA encoding a novel FGF (210 amino acids) from mouse embryos. As this is the 21st documented FGF, we tentatively term it FGF-21. FGF-21 has a hydrophobic amino terminus ( approximately 30 amino acids), which is a typical signal sequence, and appears to be a secreted protein. The expression of FGF-21 mRNA in mouse adult tissues was examined by Northern blotting analysis. FGF-21 mRNA was most abundantly expressed in the liver, and also expressed in the thymus at lower levels. We also isolated human cDNA encoding FGF-21 (209 amino acids). Human FGF-21 is highly identical ( approximately 75% amino acid identity) to mouse FGF-21. Among human FGF family members, FGF-21 is most similar ( approximately 35% amino acid identity) to FGF-19.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FGF21, unlike traditional FGFs, is an endocrine hormone produced and secreted predominantly by the liver [129,130].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [129]
Citations
Cites
Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites
Nielsen, H., Engelbrecht, J., Brunak, S., & von HEIJNE, G. (1997) · Protein Engineering Design and Selection · doi:10.1093/protein/10.1.1 · Cited by 5,343
Frohman, M. A., Dush, M. K., & Martin, G. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.8998 · Cited by 4,554
THE HEPARIN-BINDING (FIBROBLAST) GROWTH FACTOR FAMILY OF PROTEINS
Burgess, W. H., & Maciag, T. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.003043 · Cited by 1,921
The roles of FGFs in the early development of vertebrate limbs.Preprint
Martin, G. (1998) · Genes & Development · doi:10.1101/gad.12.11.1571 · Cited by 676
Miyamoto, M., Naruo, K., Seko, C., Matsumoto‐Yoshitomi, S., Kondo, T., & Kurokawa, T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4251-4259.1993 · Cited by 422
Tanaka, A., Miyamoto, K., Minamino, N., Takeda, M., Sato, B., Matsuo, H., & Matsumoto, K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.8928 · Cited by 398
Smallwood, P. M., Muñoz-Sanjuán, I., Tong, P. Y., Macke, J. P., Hendry, S. H. C., Gilbert, D. J., Copeland, N. G., Jenkins, N. A., & Nathans, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9850 · Cited by 395
The Heparan Sulfate–Fibroblast Growth Factor Family: Diversity of Structure and Function
McKeehan, W. L., Wang, F., & Kan, M. (1997) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)61031-4 · Cited by 392
The fibroblast growth factor family.
Baird, A., & Klagsbrun, M. (1991) · PubMed · Cited by 322
Yamasaki, M., Miyake, A., Tagashira, S., & Itoh, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.15918 · Cited by 288
Cited by
Sorted by citations
Items 301–400 of 846
Zhang, J., Xu, Z., Gu, J., Jiang, S., Liu, Q., Zheng, Y., Freedman, J. H., Sun, J., & Cai, L. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00465.2017 · Cited by 50
Fazeli, P. K., Faje, A. T., Cross, E. J., Lee, H., Rosen, C. J., Bouxsein, M., & Klibanski, A. (2015) · Bone · doi:10.1016/j.bone.2015.04.001 · Cited by 49
Autophagy as a crosstalk mediator of metabolic organs in regulation of energy metabolism
Kim, K. H., & Lee, M. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9272-6 · Cited by 50
Flippo, K. H., Jensen-Cody, S. O., Claflin, K. E., & Potthoff, M. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-76593-2 · Cited by 49
Fibroblast growth factor 21: an overview from a clinical perspective
Rydén, M. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0003-9 · Cited by 48
Effects of fibroblast growth factor 21 on cell damage in vitro and atherosclerosis in vivo
Zhu, W., Wang, C., Liu, L., Li, Y., Li, X., Cai, J., & Wang, H. (2014) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0227 · Cited by 48
Tomita, Y., Ozawa, N., Miwa, Y., Ishida, A., Ohta, M., Tsubota, K., & Kurihara, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235878 · Cited by 49
Vienberg, S. G., Brøns, C., Nilsson, E., Astrup, A., Vaag, A., & Andersen, B. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0039 · Cited by 47
Anorexia nervosa and bone metabolism
Fazeli, P. K., & Klibanski, A. (2014) · Bone · doi:10.1016/j.bone.2014.05.014 · Cited by 51
Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD)
Carneros, D., López‐Lluch, G., & Bustos, M. (2020) · Nutrients · doi:10.3390/nu12113472 · Cited by 48
Hepatic hormone FGF21 and its analogues in clinical trials
Shao, W., & Jin, T. (2021) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2021.08.005 · Cited by 49
(2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.07.012 · Cited by 46
Eto, K., Tumenbayar, B., Nagashima, S., Tazoe, F., Miyamoto, M., Takahashi, M., Ando, A., Okada, K., Yagyu, H., & Ishibashi, S. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.03.019 · Cited by 45
Santoso, P., Nakata, M., Shiizaki, K., Boyang, Z., Parmila, K., Otgon-Uul, Z., Hashimoto, K., Satoh, T., Mori, M., Kuro‐o, M., et al. (2017) · Scientific Reports · doi:10.1038/srep45819 · Cited by 45
Wang, N., Li, J., Li, S., Guo, X., Wu, T., Wang, W., & Li, D. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.143 · Cited by 46
Role of hepatokines in non-alcoholic fatty liver disease
Ke, Y., Xu, C., Lin, J., & Li, Y. (2019) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2019-0029 · Cited by 46
Functional Roles of FGF Signaling in Early Development of Vertebrate Embryos
Kumar, V., Goutam, R. S., Park, S., Lee, U., & Kim, J. (2021) · Cells · doi:10.3390/cells10082148 · Cited by 48
Accuracy of FGF‐21 and GDF‐15 for the diagnosis of mitochondrial disorders: A meta‐analysis
Lin, Y., Ji, K., Ma, X., Liu, S., Li, W., Zhao, Y., & Yan, C. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51104 · Cited by 48
Yu, J., Zhao, L., Wang, A., Eleswarapu, S., Ge, X., Chen, D., & Jiang, H. (2011) · Endocrinology · doi:10.1210/en.2011-1591 · Cited by 45
Metabolic actions of fibroblast growth factor 21
Ramos, D. C., Aguilar-Salinas, C. A., & Gomez-Perez, F. J. (2012) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283557d22 · Cited by 46
Stemmer, K., Zani, F., Habegger, K. M., Neff, C., Kotzbeck, P., Bauer, M., Yalamanchilli, S., Azad, A., Lehti, M., Martins, P. J. F., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3668-7 · Cited by 44
Kim, E. R., Kim, S. R., Cho, W., Lee, S., Kim, S. H., Kim, J. H., Choi, E., Kim, J., Yu, J., Lee, B., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843520 · Cited by 44
Wu, S., Grunwald, T., Kharitonenkov, A., Dam, J., Jockers, R., & Luca, F. D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.462218 · Cited by 45
RetractedLenart-Lipińska, M., Matyjaszek‐Matuszek, B., Gernand, W., Nowakowski, A. M., & Solski, J. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.04.010 · Cited by 44
Brown adipose tissue: The heat is on the heart
Thoonen, R., Hindle, A. G., & Scherrer‐Crosbie, M. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00698.2015 · Cited by 46
Association between Circulating Fibroblast Growth Factor 21 and Aggressiveness in Thyroid Cancer
Kang, Y. E., Kim, J. T., Lim, M. A., Oh, C., Liu, L., Jung, S., Won, H.-R., Lee, K.-M., Chang, J. W., Yi, H., et al. (2019) · Cancers · doi:10.3390/cancers11081154 · Cited by 44
Gao, R.-Y., Hsu, B., Wu, D.-A., Hou, J.-S., & Chen, M.-C. (2019) · International Journal of Endocrinology · doi:10.1155/2019/5163245 · Cited by 46
Modulatory Effect of Myokines on Reactive Oxygen Species in Ischemia/Reperfusion
Szabó, M. R., Pipicz, M., Csont, T., & Csonka, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249382 · Cited by 45
Gao, J., Liu, J., Meng, Z., Li, Y., Hong, Y., Wang, L., He, L., Hu, B. Q., Zheng, Y., Li, T., et al. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.06.015 · Cited by 44
Reimers, D., López-Toledano, M. A., Mason, I. J., Cuevas, P., Redondo, C., Herranz, A. S., Lobo, M. V. T., & Bazán, E. (2001) · Neurological Research · doi:10.1179/016164101101199090 · Cited by 44
Serum fibroblast growth factor 21 levels in polycystic ovary syndrome
Görar, S., Çulha, C., Üç, Z. A., Dellal, F. D., Serter, R., Aral, S., & Aral, Y. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.487587 · Cited by 43
Toloza, F. J. K., Mantilla-Rivas, J. O., Pérez-Matos, M. C., Ricardo-Silgado, M. L., Morales-Alvarez, M. C., Pinzón-Cortés, J. A., Pérez-Mayorga, M., Arévalo-Garcia, M. L., Tolosa-González, G., & Mendivil, C. O. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00005 · Cited by 42
“Fibroblast growth factor 21 (FGF-21) is a pleiotropic hormone secreted mostly by the liver (10) but also by muscle under stress (11).”
BackgroundGeng, S., Qin, L., He, Y., Li, X., Yang, M., Li, L., Liu, D., Li, Y., Niu, D., & Yang, G. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120763 · Cited by 42
Porflitt-Rodríguez, M., Guzmán-Arriagada, V., Sandoval-Valderrama, R., Tam, C. S., Pavicic, F., Ehrenfeld, P., & Martínez-Huenchullán, S. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155137 · Cited by 42
The role of microglial activation on ischemic stroke: Modulation by fibroblast growth factors
Dordoe, C., Huang, W., Bwalya, C., Wang, X., Shen, B., Wang, H., Wang, J., Ye, S., Wang, P., Xiaoyan, B., et al. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.07.005 · Cited by 44
Fibroblast growth factor (Fgf) 21 is a novel target gene of the aryl hydrocarbon receptor (AhR)
Cheng, X., Vispute, S. G., Liu, J., Cheng, C., Kharitonenkov, A., & Klaassen, C. D. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.04.013 · Cited by 42
Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis
Zhang, J.-Z., Cai, J., Yu, Y., She, Z., & Li, H. (2019) · Gene Expression · doi:10.3727/105221619x15553433838609 · Cited by 42
Torre-Villalvazo, I., Alemán, G., Valle‐Rios, R., & Noriega, L. G. (2019) · Nutrition Research · doi:10.1016/j.nutres.2019.06.006 · Cited by 45
PPARα Agonist Oral Therapy in Diabetic Retinopathy
Tomita, Y., Lee, D., Tsubota, K., & Kurihara, T. (2020) · Biomedicines · doi:10.3390/biomedicines8100433 · Cited by 42
Keulen, C. J. V. V.-V., Rauwerda, H., & Pals, G. (2005) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2004.12.029 · Cited by 42
The Roles of Fibroblast Growth Factors in the Testicular Development and Tumor
Jiang, X. M., Skibba, M. E., Zhang, C., Tan, Y., Xin, Y., & Qu, Y. (2013) · Journal of Diabetes Research · doi:10.1155/2013/489095 · Cited by 42
The roles of FGF21 in atherosclerosis pathogenesis
Shanehbandpour-Tabari, F., Karimian, A., Parsian, H., Rameshknia, V., Mahmoodpoor, A., Majidinia, M., Maniati, M., & Yousefi, B. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09488-x · Cited by 41
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
Finney, A. C., Das, S., Kumar, D., McKinney, M. P., Cai, B., Yurdagul, A., & Rom, O. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1116861 · Cited by 40
Oishi, K., Konishi, M., Murata, Y., & Itoh, N. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.125 · Cited by 40
Taniguchi, H., Tanisawa, K., Sun, X., Cao, Z., Oshima, S., Ise, R., Sakamoto, S., & Higuchi, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1877 · Cited by 40
Fibroblast growth factor 21 in chronic kidney disease
Anuwatmatee, S., Tang, S., Wu, B. J., Rye, K., & Ong, K. L. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.11.002 · Cited by 40
Targeting Neurovascular Interaction in Retinal Disorders
Fu, Z., Sun, Y., Cakir, B., Tomita, Y., Huang, S., Wang, Z., Liu, C., Cho, S. S., Britton, W. R., Kern, T. S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041503 · Cited by 43
SIRT1 Mediates Effects of FGF21 to Ameliorate Cisplatin-Induced Acute Kidney Injury
Chen, Q., Ma, J., Yang, X., Li, Q., Lin, Z., & Gong, F. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00241 · Cited by 40
The regulation of healthspan and lifespan by dietary amino acids
Babygirija, R., & Lamming, D. W. (2021) · Translational Medicine of Aging · doi:10.1016/j.tma.2021.05.001 · Cited by 43
Li, X.-H., Liu, L., Chen, L., Pan, Q., Ouyang, Z., Fan, D., Pan, X., Lu, S.-Y., Luo, Q.-H., Tao, P., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273527 · Cited by 40
Tian, S., Zhao, H., & Song, H. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2148090 · Cited by 42
Amiri, M., Braidy, N., & Aminzadeh, M. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9914-2 · Cited by 38
Exercise ameliorates the FGF21–adiponectin axis impairment in diet-induced obese mice
Yang, W., Liu, L., Wei, Y., Fang, C., Zhou, F., Chen, J., Han, Q., Huang, M., Tan, X., Liu, Q., et al. (2019) · Endocrine Connections · doi:10.1530/ec-19-0034 · Cited by 39
FGF21 and Chronic Kidney Disease.
Salgado, J., Goes, M. A., & Salgado, N. (2021) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2021.154738 · Cited by 35
Tian, S., Wang, Y., Li, X., Liu, J., Wang, J., & Lu, Y. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c04933 · Cited by 40
Patel, S., Haider, A., Álvarez-Guaita, A., Bidault, G., Moustafa, J. S. E.-S., Guiu‐Jurado, E., Tadross, J. A., Warner, J., Harrison, J., Virtue, S., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101589 · Cited by 42
Liver Brain Interactions: Focus on FGF21 a Systematic Review
Prida, E., Álvarez-Delgado, S., Pérez-Lois, R., Soto-Tielas, M., Estany‐Gestal, A., Fernø, J., Seoane, L. M., Quiñones, M., & Al–Massadi, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113318 · Cited by 40
Charoenphandhu, N., Suntornsaratoon, P., Krishnamra, N., Sa‐nguanmoo, P., Tanajak, P., Wang, X., Liang, G., Li, X., Jiang, C., Chattipakorn, N., et al. (2016) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-016-0745-z · Cited by 38
A review of fibroblast growth factor 21 in diabetic cardiomyopathy
Zhang, X., Luo, Y., Xu, X., Tang, F., Yi, P., Qiu, B., & Hao, Y. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09809-x · Cited by 39
Fgf21 is essential for haematopoiesis in zebrafish
Yamauchi, H., Hotta, Y., Konishi, M., Miyake, A., Kawahara, A., & Itoh, N. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400685 · Cited by 38
Chalvon-Demersay, T., Even, P. C., Tomé, D., Chaumontet, C., Piedcoq, J., Gaudichon, C., & Azzout-Marniche, D. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.07.002 · Cited by 37
Fibroblast growth factor 21 in metabolic syndrome
Yang, M., Liu, C., Jiang, N., Liu, Y., Luo, S., Li, C., Zhao, H., Han, Y., Chen, W., Li, L., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1220426 · Cited by 40
Jin, Q., Bando, Y., Miyawaki, K., Shikama, Y., Kosugi, C., Aki, N., Funaki, M., & Noji, S. (2014) · The Journal of Medical Investigation · doi:10.2152/jmi.61.28 · Cited by 37
Novel Mediators of Adipose Tissue and Muscle Crosstalk
Indrakusuma, I., Sell, H., & Eckel, J. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0174-7 · Cited by 38
Biomarkers of Metabolic Syndrome: Biochemical Background and Clinical Significance
Robberecht, H. J., & Hermans, N. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0113 · Cited by 38
Izaguirre, M., Gil, M. J., Monreal, I., Montecucco, F., Frühbeck, G., & Catalán, V. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0866-3 · Cited by 41
Cardioprotective mechanisms activated in response to myocardial ischemia.
Liu, S. Q., Tefft, B. J., Zhang, D., Roberts, D., Schuster, D. J., & Wu, A. (2011) · PubMed · Cited by 36
Li, S., Zou, T., Chen, J., Li, J., & You, J. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.06.033 · Cited by 37
Therapeutic Approaches to Alzheimer’s Type of Dementia: A Focus on FGF21 Mediated Neuroprotection
Taliyan, R., Chandran, S. K., & Kakoty, V. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190716101411 · Cited by 35
Li, S., Wang, W., Zhou, L., Ma, L., An, Y., Xu, W.-J., Li, T.-H., Yu, Y.-H., Li, D., & Liú, Y. (2014) · Endocrine · doi:10.1007/s12020-014-0309-8 · Cited by 36
Li, K., Li, L., Yang, M., Zong, H., Liu, H., & Yang, G. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0335 · Cited by 36
Elevated Serum Fibroblast Growth Factor 21 in Humans with Acute Pancreatitis
Shenoy, V. K., Beaver, K. M., Fisher, F. M., Singhal, G., Dushay, J. R., Maratos–Flier, E., & Flier, S. N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164351 · Cited by 36
Xu, T., Zhu, Q., Huang, Q., Gu, Q., Zhu, Y., Tang, M., Tian, S., Wang, L., Yan, F., Ge, J., et al. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110753 · Cited by 35
FGF21 modulates immunometabolic homeostasis via the ALOX15/15-HETE axis in early liver graft injury
Yang, X., Chen, H. H., Shen, W., Chen, Y., Lin, Z., Zhuo, J., Wang, S., Yang, M., Li, H., He, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52379-2 · Cited by 35
FGF21, energy expenditure and weight loss – How much brown fat do you need?
Straub, L. G., & Wolfrum, C. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.06.008 · Cited by 35
Leptin as a Potential Regulator of FGF21
Asrih, M., Veyrat‐Durebex, C., Poher, A.-L., Lyautey, J., Rohner‐Jeanrenaud, F., & Jornayvaz, F. R. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000443070 · Cited by 35
Metabolic actions of FGF21: molecular mechanisms and therapeutic implications
Ge, X., Wang, Y., Lam, K. S., & Xu, A. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.06.011 · Cited by 35
Rani, S. G., Sepuru, K. M., & Yu, C. (2010) · Biochemistry · doi:10.1021/bi9019077 · Cited by 35
Lotfi, C. F. P., & Armelin, H. A. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1680381 · Cited by 35
Kotulák, T., Drápalová, J., Kopecky, P., Lacinová, Z., Kramar, P., Říha, H., Netuka, I., Malý, J., Housa, D., Bláha, J., et al. (2011) · Physiological Research · doi:10.33549/physiolres.932134 · Cited by 35
Recently Discovered Adipokines and Cardio-Metabolic Comorbidities in Childhood Obesity
Barraco, G. M., Luciano, R., Semeraro, M., Prieto-Hontoria, P. L., & Manco, M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151119760 · Cited by 33
Endogenous ways to stimulate brown adipose tissue in humans
Broeders, E. P. M., Bouvy, N. D., & Lichtenbelt, W. D. V. M. (2014) · Annals of Medicine · doi:10.3109/07853890.2013.874663 · Cited by 37
Modulation of energy balance by fibroblast growth factor 21
Ramos, D. C., & Aguilar-Salinas, C. A. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0023 · Cited by 36
Hepatic FGF21: Its Emerging Role in Inter-Organ Crosstalk and Cancers
Sui, Y., & Chen, J. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.76924 · Cited by 33
Nguyen, A. N., Song, J.-A., Nguyen, M. T., Do, B. H., Kwon, G. G., Park, S. S., Yoo, J., Jang, J., Jin, J., Osborn, M. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16167-x · Cited by 33
Basurto, L., Gregory, M. A., Barrera-Hernández, S., Sánchez-Huerta, L., Martínez, A. D., Manuel‐Apolinar, L., Avelar‐Garnica, F. J., Alonso, L. A. M., & Sánchez‐Arenas, R. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.05.013 · Cited by 33
Wang, N., Zhao, T., Li, S., Li, Y., Wang, Y., Li, D., & Wang, W. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.06.002 · Cited by 33
Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling
Agrawal, S., Maity, S., Alraawi, Z., Al-Ameer, M., & Kumar, T. K. S. (2020) · Current Drug Targets · doi:10.2174/1389450121999201012201926 · Cited by 34
Kim, W. J., Kim, S. S., Lee, H. C., Song, S. H., Bae, M. J., Yi, Y., Jeon, Y. K., Kim, B. H., Kim, Y. K., & Kim, I. J. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.5.586 · Cited by 33
Plasma Concentrations of Fibroblast Growth Factors 21 and 19 in Patients with Cushing's Syndrome
Ďurovcová, V., Marek, J., Hána, V., Matoulek, M., Zikán, V., Haluzíková, D., Kaválková, P., Lacinová, Z., Kršek, M., & Haluzı́k, M. (2010) · Physiological Research · doi:10.33549/physiolres.931801 · Cited by 33
Sun, L., Yan, J., Goh, H. J., Govindharajulu, P., Verma, S. K., Michael, N., Sadananthan, S. A., Henry, C. J., Velan, S. S., & Leow, M. K. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa005 · Cited by 35
Heparan sulfate-growth factor interactions
Rapraeger, A. C. (2002) · Methods in cell biology · doi:10.1016/s0091-679x(02)69009-0 · Cited by 33
Yadav, P., Khurana, A., Bhatti, J. S., Weiskirchen, R., & Navik, U. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106426 · Cited by 32
Bone Metabolism in Anorexia Nervosa
Fazeli, P. K., & Klibanski, A. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-013-0186-8 · Cited by 37
A systematic dissection of sequence elements determining β-Klotho and FGF interaction and signaling
Shi, S. Y., Lu, Y., Richardson, J., Min, X., Weiszmann, J., Richards, W. G., Wang, Z., Zhang, Z., Zhang, J., & Li, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-29396-5 · Cited by 31
Long-Acting FGF21 Inhibits Retinal Vascular Leakage in In Vivo and In Vitro Models
Tomita, Y., Fu, Z., Wang, Z., Cakir, B., Cho, S. S., Britton, W. R., Sun, Y., Hellström, A., Talukdar, S., & Smith, L. E. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041188 · Cited by 32
Kim, J. B., Lee, G. Y., Maeng, H. J., Kim, H., Bae, J. H., Kim, K. M., & Lim, S. K. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2020.781 · Cited by 33
A solid-phase PEGylation strategy for protein therapeutics using a potent FGF21 analog
Song, L., Zhu, Y., Wang, H., Belov, A. A., Niu, J., Shi, L., Xie, Y., Ye, C., Li, X., & Huang, Z. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.023 · Cited by 32
Fibroblast growth factor 21: a promising therapeutic target in obesity-related diseases
Cheung, B. M. Y., & Deng, H. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.904745 · Cited by 32
McCarty, M. F. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.06.014 · Cited by 32
Metadata
- Authors
- Nishimura, T., Nakatake, Y., Konishi, M., & Itoh, N.
- Affiliations
- Kyoto University (JP)
- Corresponding author
- Itoh, Nobuyuki
- Venue
- Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
- Publisher
- Elsevier BV
- Published
- 2000-06
- Volume
- 1492
- Issue
- 1
- Pages
- 203-206
- ISSN
- 0167-4781 (ISSN-L)
- OpenAlex
- W1989584881
- Cited by
- 847
- References
- 21
- Citations by year
- 2026: 14 · 2025: 48 · 2024: 63 · 2023: 47 · 2022: 41 · 2021: 62 · 2020: 49 · 2019: 56 · 2018: 41 · 2017: 46 · 2016: 53 · 2015: 53 · 2014: 43 · 2013: 34 · 2012: 44
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Keywords
- FGF21, fibroblast growth factor, liver-specific gene expression, thymus, signal peptide, secreted proteins, cDNA cloning, mouse embryo, FGF19, amino acid sequence identity, tissue distribution
- MeSH terms
- Amino Acid Sequence, Animals, Embryo, Mammalian, Fibroblast Growth Factors, Humans, Liver, Molecular Sequence Data, Phylogeny, Sequence Homology, Amino Acid, DNA, Complementary, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review